Skip to main content
. Author manuscript; available in PMC: 2024 Aug 14.
Published in final edited form as: Pharmacotherapy. 2017 Nov 27;37(12):1489–1497. doi: 10.1002/phar.2049

Figure 3.

Figure 3.

(A–D) Overall per patient cost of Clostridium difficile–associated diarrhea (CDAD) treatment in different patient populations. FDX = fidaxomicin; rCDAD = recurrent C. difficile–associated diarrhea; VAN = vancomycin.